Hypertension: Its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region

Journal of Hypertension

Volumn 25, Issue 1, 2007, Pages 73-79

  Martiniuk, Alexandra Lc ^a,i   Lee, Crystal My ^a   Lawes, Carlene M M ^b   Ueshima, Hirotsugu ^c   Suh, Il ^d   Lam, Tai Hing ^e   Gu, Dongfeng ^f   Feigin, Valery ^b   Jamrozik, Konrad ^g   Ohkubo, Takayoshi ^h   Woodward, Mark ^a  

^a GEORGE INSTITUTE FOR INTERNATIONAL HEALTH   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d Yonsei University   (South Korea)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f PEKING UNION MEDICAL COLLEGE   (China)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h TOHOKU UNIVERSITY   (Japan)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Attributable fraction; Heart disease; Hypertension; South east Asia; Stroke; Western Pacific

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASIA; CARDIOVASCULAR DISEASE; CHILD; COHORT ANALYSIS; FATALITY; FEMALE; GENDER; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MORTALITY; PACIFIC ISLANDER; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SOUTHEAST ASIA; STROKE; WORLD HEALTH ORGANIZATION;

EID: 33845353295     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328010775f     Document Type: Article

References (39)

1. Murray CJL, Lopez AD (editors). Global health statistics: a compendium of incidence, prevalence and mortality for over 200 conditions. Global burden of disease. Cambridge, MA: Harvard University Press; 1996.
2. Tunstall-Pedoe H (editor). MONICA monograph and multimedia sourcebook. Geneva: World Health Organization; 2003.
3. World Health Organization and the Public Health Agency of Canada. Preventing chronic diseases: a vital investment; 2005. http://www.who.int/chp/ chronic_disease_report/contents/en/index.html [Accessed 31 May 2006].
4. Asia-Pacific Cohort Studies Collaboration. Writing Committee: Lawes CMM, Bennett DA, Parag V, Woodward M, Whitlock G, Lam TH, et al. Blood pressure indices and cardiovascular disease in the Asia-Pacific region: a pooled analysis. Hypertension 2003; 42:69-75.
5. Asia-Pacific Cohort Studies Collaboration. Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306,620 participants. Stroke 2005; 36:1360-1365.
6. Ezzati M, Lopez AD, Rodgers A, VanderHoorn S, Murray CJL, Comparative Risk Assessment Collaborative Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360:1347-1360.
7. Population Reference Bureau. 2004 World population data sheet. www.prb.org [Accessed 29 June 2005].
8. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11-19.
9. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
10. Lawes CMM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels. J Hypertens 2006; 24:413-422.
11. Lawes CMM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. J Hypertens 2006; 24:423-430.
12. Asia-Pacific Cohort Studies Collaboration. Writing Committee: Lawes CMM, Rodgers A, Bennet DA, Parag V, Suh I, Ueshima H, MacMahon S. Blood pressure and cardiovascular disease in the Asia-Pacific region. J Hypertens 2003; 21:707-716.
13. Woodward M. Epidemiology study design and data analysis, 2nd edn. London: Chapman and Hall; 2005.
14. Ahmad OB, Bshchi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M, for the World Health Organization. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: No 31. Available at: http://www3.who.int/whosis/ discussion_papers/pdf/paper31.pdf [Accessed 19 June 2006].
15. Asia-Pacific Cohort Studies Collaboration. Determinants of cardiovascular disease in the Asia-Pacific region: protocol for a collaborative overview of cohort studies. Cardiovasc Dis Prev 1999; 2:281-289.
16. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
17. World Health Organization. http://www.who.int/ncd_surveillance/infobase/ web//InfoBasePolicyMaker/CountryProfiles/CountryProfile.aspx?UN_Code= 410&comp=0&dm=18 [Accessed 03 June 2006].
18. Sayeed MA, Banu A, Haq JA, Khanam PA, Mahtab H, Azad Khan AK. Prevalence of hypertension in Bangladesh: effect of socioeconomic risk factor on difference between rural and urban community. Med Res Counc Bull 2002; 28:7-18.
19. Gu D, Reynolds K, Wu K, Chen J, Duan X, Muntner P, et al., InterAsia Collaborative Group. Prevalence, awareness, treatment and control of hypertension in China. Hypertension 2002; 40:920-927.
20. World Health Organization. http://www.who.int/ncd_surveillance/infobase/ web//InfoBasePolicyMaker/CountryProfiles/CountryProfile.aspx?UN_Code= 242&comp=0&dm=18 [Accessed 06 July 2005].
21. Hong Kong Population Health Survey 2003-2004. Available at: http://www.info.gov.hk/dh/diseases/phs/0304.htm [Accessed 03 July 2006].
22. World Health Organization. http://www.who.int/ncd_surveillance/infobase/ web//InfoBasePolicyMaker/CountryProfiles/CountryProfile.aspx?UN_Code= 360&comp=0&dm=18 [Accessed 06 July 2005].
23. World Health Organization. http://www.who.int/ncd_surveillance/infobase/ web//InfoBasePolicyMaker/CountryProfiles/CountryProfile.aspx?UN_Code= 392&comp=0&dm=18 [Accessed 06 July 2005].
24. Lim TO, Morad Z, Group HS. Prevalence, awareness, treatment and control of hypertension in the Malaysian adult population: results from the National Health and Morbidity Survey 1996. Singapore Med J 2004; 45:20-27.
25. World Health Organization. http://www.who.int/ncd_surveillance/infobase/ web//InfoBasePolicyMaker/CountryProfiles/CountryProfile.aspx?UN_Code= 496&comp=0&dm=18 [Accessed 06 July 2005].
26. Russell DG, Parnell WR, Wilson NC, Faed J, Ferguson E, Herbison P, et al. NZ food: NZ people. Key results of the 1997 National Nutrition Survey. Wellington, New Zealand: Ministry of Health; 1999.
27. Tanchoco CC, Cruz AJ, Duante CA, Litonjua AD. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over. Asia Pacific J Clin Nutr 2003; 12:271-276.
28. World Health Organization. http://www.who.int/ncd_surveillance/infobase/ web//InfoBasePolicyMaker/CountryProfiles/CountryProfile.aspx?UN_Code= 392&comp=0&dm=18 [Accessed 06 July 2005].
29. World Health Organization. http://www.who.int/ncd_surveillance/infobase/ web//InfoBasePolicyMaker/CountryProfiles/CountryProfile.aspx?UN_Code= 410&comp=0&dm=18 [Accessed 06 July 2005].
30. Pan WH, Chang HY, Yeh WT, Hsiao SY, Hung YT. Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996. J Hum Hypertens 2001; 15:793-798.
31. InterASIA Collaborative Group. Cardiovascular risk factors in urban and rural Thailand - the International collaborative study of cardiovascular diseases in Asia (InterASIA). Eur J Cardiovasc Prev Rehabil 2003; 10:249-257.
32. Guidelines Sub-Committee. 1999 World Health Organization-International Society for Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
33. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289:2560-2572.
34. Robinson R. The fetal origins of adult disease. BMJ 2001; 322:375-376.
35. Amit XG, Moist L, Matsell D, Thiessen-Phillbrook HR, Haynes RB, Suri RS, et al. Risk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking water. CMAJ 2005; 173:261-268.
36. Fujimoto WY, Bergstrom RW, Boyko EJ, Leonetti DL, Newell-Moris LL, Wahl PW. Susceptibility to development of central adiposity among populations. Obes Res 1995; 3:179S-186S.
37. Wang L, Kong L, Wu F, Bai Y, Burton R. Preventing chronic disease in China. Lancet 2005; 366:1821-1824.
38. World Health Organization. Preventing chronic diseases: a vital investment 2005. http://www.who.int/chp/chronic_disease_report/en/index.html [Accessed 07September 2005].
39. Leeder S, Raymond S, Greenberg H, Liu H. The Initiative for Cardiovascular Health Research in Developing Countries. A Race Against Time: The Challenge of Cardiovascular Disease in Developing Economies. Ithaca, NY: Columbia University; 2004; http://www.ichealth.org/RaceAgainstTime.html [Accessed: 26 may 2005].